NDC 36987-3417

Saltbush

Saltbush

Saltbush is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Atriplex Wrightii Pollen.

• Product ID: 36987-3417_39113b10-fd1f-4cfc-8432-755a1686fcc4
• NDC: 36987-3417
• Product Type: Human Prescription Drug
• Proprietary Name: Saltbush
• Generic Name: Saltbush
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: ATRIPLEX WRIGHTII POLLEN
• Active Ingredient Strength: 40000 [PNU]/mL
• Pharm Classes: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-3417-3

30 mL in 1 VIAL, MULTI-DOSE (36987-3417-3)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-3417-3 [36987341703]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3417-4 [36987341704]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3417-2 [36987341702]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3417-1 [36987341701]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ATRIPLEX WRIGHTII POLLEN	40000 [PNU]/mL

OpenFDA Data

• SPL SET ID: a63e5aef-44c2-4f90-a33d-91ec10298089
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • U2AI3H2J5Y
  • 92N6W6KO2G
  • 2A64U81OQ3
  • 68R9X9Y96X
  • 098LKX5NCN
  • 380W4HYR6N
  • YB1308W43O
  • 644CZ16IR5
  • BBO1IJ3ZIW
  • DO87T1U2CI
  • YI19RB8YFD
  • JQ87AA60GU
  • 6532U64A3X
  • 81GS97HVFO
  • RX18M46K8L
  • 86LWA5503I
  • 2MH135KC6G
  • 5W6JAI84OI
  • V825XJG64G
  • 1GH3WV23KH
  • 2QOF601J1M
  • WIB701MW2H
  • WQ3S5294XY
  • N52MIQ81ZW
  • O4AB4546TP
  • DNB59M1NVU
  • 26U0BU8G83
  • B67NF86HF0
  • 57KIJ4772H
  • ANT994T71D
  • KU1V1898XX
  • 13KFG30UBR
  • 73B14PX5FW
• RxNorm Concept Unique ID - RxCUI:
  • 897968
  • 896133
  • 897315
  • 896281
  • 1006367
  • 895914
  • 895614
  • 896290
  • 1006488
  • 895679
  • 896265
  • 897977
  • 896302
  • 896080
  • 897402
  • 1013974
  • 897959
  • 897951
  • 896198
  • 897998
  • 901477
  • 896173
  • 896158
  • 1006359
  • 897376
  • 897327
  • 1013976
  • 896211
  • 895728
  • 897343
  • 897533
  • 898339
  • 896114
  • 896257
  • 901495
  • 897384
  • 1013991

Pharmacological Class

• Non-Standardized Pollen Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Pollen [CS]
• Allergens [CS]

NDC Crossover Matching brand name "Saltbush" or generic name "Saltbush"

NDC	Brand Name	Generic Name
36987-3413	Saltbush	Saltbush
36987-3414	Saltbush	Saltbush
36987-3415	Saltbush	Saltbush
36987-3416	Saltbush	Saltbush
36987-3417	Saltbush	Saltbush
36987-3418	Saltbush	Saltbush
36987-3419	Saltbush	Saltbush
36987-3420	Saltbush	Saltbush